Floatz logo

ZIPRASIDONE

Affective Disorders

Medical College of WisconsinSmall moleculePhase 4 / ApprovedDormant
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Affective Disorders cohort.

Asset / SponsorPhaseRating
Sertraline
Duke University
Phase 2/3B
Haloperidol
Duke University
Phase 2/3B

Same molecule, other indications

ZIPRASIDONE is also rated in:

schizoaffective disorderDormant
BBB
Indicative ·
76 / 100
View asset →
Depression, BipolarDormant
BBB
Indicative ·
73 / 100
View asset →
psychotic disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →